TIDMAMS
RNS Number : 9541J
Advanced Medical Solutions Grp PLC
29 April 2022
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Annual Report, Notice of Annual General Meeting and Board
Change
Winsford, UK - 29 April 2022: Advanced Medical Solutions Group
plc (AIM: AMS), the world-leading specialist in tissue-healing
technologies , announces that the Annual Report and Accounts for
the year ended 31 December 2021 and Notice of Annual General
Meeting were posted to shareholders today and are available on the
Investor Relations section of the Group's website.
Annual General Meeting
The Board continues to monitor the COVID-19 pandemic and our
priority at this time remains the health, safety and wellbeing of
all of our stakeholders. We are delighted that, at the time of
issuing this Notice, we will be able to hold the AGM with no
COVID-19 restrictions. However, the Board recognises that the
COVID-19 pandemic is an evolving situation and that it may be
necessary to modify our AGM arrangements. The arrangements are
therefore subject to change, including at short notice, if
circumstances and/or public health guidance changes .
The Board therefore recommends that you monitor the Company's
announcements for any updates and register to receive our RNS
alerts at www.admedsol.com/ investor-relations/alert-service.
The Notice of Annual General Meeting and proxy forms were posted
to shareholders today and are available on the Group's website at
www.admedsol.com/investor-relations . The AGM will be convened with
the minimum necessary quorum of two shareholders. The outcome of
the resolutions will as usual be determined by shareholder vote
based on the proxy votes received.
Shareholders are strongly encouraged to vote by proxy on the
resolutions contained in the AGM Notice and to appoint the
"Chairman of the Meeting" as their proxy, providing instructions on
how the Chair should vote on the proposed resolutions. This will
ensure that your votes will be counted if you (or any other proxy
who you might otherwise appoint) choose not to attend the AGM in
person.
To ensure votes are counted at the AGM, completed proxy forms
should be returned to: Link Group, PXS, 10th Floor, Central Square,
29 Wellington Street, Leeds, LS1 4DL and must be received by 11:00
am on 6 June 2022 in order to be valid. This is particularly
important given potential delays due to the continued impact of
COVID-19, which could potentially cause delays to the collection
and delivery of postal services. Any shareholder who wishes to
attend the AGM in person is asked to register their intention to do
so as soon as practicable.
The results of the AGM will be announced to the London Stock
Exchange and placed on the Group's website, in the usual way, as
soon as practicable after the conclusion of the AGM.
Non-Executive Board Refreshment
As reported previously, in accordance with the 2018 UK Corporate
Governance Code the Group is implementing a plan to refresh the
Non-Executive members of its Board, which began in 2020 and is
expected to complete in 2023.
Having appointed Grahame Cook and Douglas Le Fort as
Non-Executive Directors in 2021, Penny Freer is due to retire from
the Board at the upcoming AGM. It is expected that Douglas Le Fort
will become Chair of the Remuneration Committee, having worked
closely with Penny since he joined the Remuneration Committee in
2021. The Board would like to thank Penny for her significant
contribution to the success of AMS over the last twelve years.
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Matthew AMS@consilium-comms.com
Cole
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Gary Clarence
HSBC Bank PLC (Broker) Tel: 44 (0) 20 7991
8888
Sam McLennan / Joe Weaving / Stephanie
Cornish
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative tissue-healing technology, focused on quality outcomes
for patients and value for payers. AMS has a wide range of surgical
products including tissue adhesives, sutures, haemostats, internal
fixation devices and internal sealants, which it markets under its
brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) .
AMS also supplies wound care dressings such as silver alginates,
alginates and foams through its ActivHeal(R) brand as well as under
white label. Since 2019, the Group has made three acquisitions:
Sealantis, an Israeli medical device company with a
patent-protected sealant technology platform; Biomatlante, an
established French developer and manufacturer of innovative
surgical biomaterial technologies and Raleigh, a UK leading coater
and converter of materials predominately for woundcare and
bio-diagnostics products.
AMS's products, manufactured in the UK, Germany, France, the
Netherlands, the Czech Republic and Israel, are sold globally via a
network of multinational or regional partners and distributors, as
well as via AMS's own direct sales forces in the UK, Germany, the
Czech Republic and Russia. The Group has R&D innovation hubs in
the UK, Germany, France and Israel. Established in 1991, the Group
has more than 700 employees. For more information, please see
www.admedsol.com .
.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAQKLFLLZLZBBX
(END) Dow Jones Newswires
April 29, 2022 12:43 ET (16:43 GMT)
Advanced Medical Solutions (AQSE:AMS.GB)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Advanced Medical Solutions (AQSE:AMS.GB)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024